174 related articles for article (PubMed ID: 23959162)
1. Cholinergic manipulation of motor disability and L-DOPA-induced dyskinesia in 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP)-treated common marmosets.
Jackson MJ; Swart T; Pearce RK; Jenner P
J Neural Transm (Vienna); 2014 Feb; 121(2):163-9. PubMed ID: 23959162
[TBL] [Abstract][Full Text] [Related]
2. The dopamine D(2) receptor partial agonist aplindore improves motor deficits in MPTP-treated common marmosets alone and combined with L-dopa.
Jackson MJ; Andree TH; Hansard M; Hoffman DC; Hurtt MR; Kehne JH; Pitler TA; Smith LA; Stack G; Jenner P
J Neural Transm (Vienna); 2010 Jan; 117(1):55-67. PubMed ID: 19809864
[TBL] [Abstract][Full Text] [Related]
3. GDNF reverses priming for dyskinesia in MPTP-treated, L-DOPA-primed common marmosets.
Iravani MM; Costa S; Jackson MJ; Tel BC; Cannizzaro C; Pearce RK; Jenner P
Eur J Neurosci; 2001 Feb; 13(3):597-608. PubMed ID: 11168568
[TBL] [Abstract][Full Text] [Related]
4. The selective 5-HT
Fisher R; Hikima A; Morris R; Jackson MJ; Rose S; Varney MA; Depoortere R; Newman-Tancredi A
Neuropharmacology; 2020 May; 167():107997. PubMed ID: 32057799
[TBL] [Abstract][Full Text] [Related]
5. L-DOPA-induced behavioral sensitization of motor activity in the MPTP-treated common marmoset as a Parkinson's disease model.
Ando K; Inoue T; Itoh T
Pharmacol Biochem Behav; 2014 Dec; 127():62-9. PubMed ID: 25449794
[TBL] [Abstract][Full Text] [Related]
6. The novel adenosine A2a receptor antagonist ST1535 potentiates the effects of a threshold dose of L-DOPA in MPTP treated common marmosets.
Rose S; Jackson MJ; Smith LA; Stockwell K; Johnson L; Carminati P; Jenner P
Eur J Pharmacol; 2006 Sep; 546(1-3):82-7. PubMed ID: 16925991
[TBL] [Abstract][Full Text] [Related]
7. Actions of the D1 agonists A-77636 and A-86929 on locomotion and dyskinesia in MPTP-treated L-dopa-primed common marmosets.
Pearce RK; Jackson M; Britton DR; Shiosaki K; Jenner P; Marsden CD
Psychopharmacology (Berl); 1999 Feb; 142(1):51-60. PubMed ID: 10102782
[TBL] [Abstract][Full Text] [Related]
8. The monoamine reuptake inhibitor BTS 74 398 fails to evoke established dyskinesia but does not synergise with levodopa in MPTP-treated primates.
Hansard MJ; Smith LA; Jackson MJ; Cheetham SC; Jenner P
Mov Disord; 2004 Jan; 19(1):15-21. PubMed ID: 14743355
[TBL] [Abstract][Full Text] [Related]
9. 3,4-methylenedioxymethamphetamine (ecstasy) inhibits dyskinesia expression and normalizes motor activity in 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-treated primates.
Iravani MM; Jackson MJ; Kuoppamäki M; Smith LA; Jenner P
J Neurosci; 2003 Oct; 23(27):9107-15. PubMed ID: 14534244
[TBL] [Abstract][Full Text] [Related]
10. The partial dopamine agonist pardoprunox (SLV308) administered in combination with l-dopa improves efficacy and decreases dyskinesia in MPTP treated common marmosets.
Tayarani-Binazir K; Jackson MJ; Rose S; McCreary AC; Jenner P
Exp Neurol; 2010 Dec; 226(2):320-7. PubMed ID: 20843474
[TBL] [Abstract][Full Text] [Related]
11. Antiparkinsonian activity and dyskinesia risk of ropinirole and L-DOPA combination therapy in drug naïve MPTP-lesioned common marmosets (Callithrix jacchus).
Maratos EC; Jackson MJ; Pearce RK; Jenner P
Mov Disord; 2001 Jul; 16(4):631-41. PubMed ID: 11481686
[TBL] [Abstract][Full Text] [Related]
12. Continuous administration of rotigotine to MPTP-treated common marmosets enhances anti-parkinsonian activity and reduces dyskinesia induction.
Stockwell KA; Scheller D; Rose S; Jackson MJ; Tayarani-Binazir K; Iravani MM; Smith LA; Olanow CW; Jenner P
Exp Neurol; 2009 Oct; 219(2):533-42. PubMed ID: 19619533
[TBL] [Abstract][Full Text] [Related]
13. Effect of pulsatile administration of levodopa on dyskinesia induction in drug-naïve MPTP-treated common marmosets: effect of dose, frequency of administration, and brain exposure.
Smith LA; Jackson MJ; Hansard MJ; Maratos E; Jenner P
Mov Disord; 2003 May; 18(5):487-95. PubMed ID: 12722161
[TBL] [Abstract][Full Text] [Related]
14. Multiple small doses of levodopa plus entacapone produce continuous dopaminergic stimulation and reduce dyskinesia induction in MPTP-treated drug-naive primates.
Smith LA; Jackson MJ; Al-Barghouthy G; Rose S; Kuoppamaki M; Olanow W; Jenner P
Mov Disord; 2005 Mar; 20(3):306-14. PubMed ID: 15490461
[TBL] [Abstract][Full Text] [Related]
15. Both short- and long-acting D-1/D-2 dopamine agonists induce less dyskinesia than L-DOPA in the MPTP-lesioned common marmoset (Callithrix jacchus).
Maratos EC; Jackson MJ; Pearce RK; Cannizzaro C; Jenner P
Exp Neurol; 2003 Jan; 179(1):90-102. PubMed ID: 12504871
[TBL] [Abstract][Full Text] [Related]
16. De novo administration of ropinirole and bromocriptine induces less dyskinesia than L-dopa in the MPTP-treated marmoset.
Pearce RK; Banerji T; Jenner P; Marsden CD
Mov Disord; 1998 Mar; 13(2):234-41. PubMed ID: 9539335
[TBL] [Abstract][Full Text] [Related]
17. The highly selective 5-HT
Hamadjida A; Nuara SG; Bédard D; Gaudette F; Beaudry F; Gourdon JC; Huot P
Neuropharmacology; 2018 Sep; 139():61-67. PubMed ID: 29969592
[TBL] [Abstract][Full Text] [Related]
18. Antiparkinsonian Effects of a Metabotropic Glutamate Receptor 4 Agonist in MPTP-Treated Marmosets.
Mann E; Jackson M; Lincoln L; Fisher R; Rose S; Duty S
J Parkinsons Dis; 2020; 10(3):959-967. PubMed ID: 32250315
[TBL] [Abstract][Full Text] [Related]
19. Trazodone alleviates both dyskinesia and psychosis in the parkinsonian marmoset model of Parkinson's disease.
Hamadjida A; Nuara SG; Gourdon JC; Huot P
J Neural Transm (Vienna); 2018 Sep; 125(9):1355-1360. PubMed ID: 29247391
[TBL] [Abstract][Full Text] [Related]
20. Continuous rotigotine administration reduces dyskinesia resulting from pulsatile treatment with rotigotine or L-DOPA in MPTP-treated common marmosets.
Stockwell KA; Scheller DK; Smith LA; Rose S; Iravani MM; Jackson MJ; Jenner P
Exp Neurol; 2010 Jan; 221(1):79-85. PubMed ID: 19833125
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
